Retefast 18mg Injection
Prescription Required
Product introduction
Retefast 18mg Injection is a medicine that dissolves clots that have formed in blood vessels. It is used to treat a heart attack. It is known as a thrombolytic or “clot-busting” drug. This medicine restores the blood flow to the affected tissue, thereby preventing tissue death.
It is a thrombolytics
It is a thrombolytics
Uses of Retefast Injection
Benefits of Retefast Injection
In Heart attack
Retefast 18mg Injection dissolves harmful blood clots that cause heart attack (if they are in the heart). They also dissolve clots that form in other blood vessels. This means that blood can again start to flow freely through your body. This medicine will, therefore, reduce both the damage caused by, and the risk of dying from a heart attack. The sooner the injection is given, the greater are the chances of recovery.
Side effects of Retefast Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Retefast
- Bleeding disorder
- Nausea
- Vomiting
- Decreased blood pressure
- Injection site bleeding
How to use Retefast Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Retefast 18mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Retefast 18mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Retefast 18mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
NOT RELEVANT
Not relevant, as Retefast 18mg Injection is intended for use in hospitalised patients.
Kidney
CAUTION
Retefast 18mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Retefast 18mg Injection may be needed. Please consult your doctor.
Use of Retefast 18mg Injection is not recommended in patients with severe kidney disease.
Use of Retefast 18mg Injection is not recommended in patients with severe kidney disease.
Liver
CAUTION
Retefast 18mg Injection should be used with caution in patients with liver disease. Dose adjustment of Retefast 18mg Injection may be needed. Please consult your doctor.
Use of Retefast 18mg Injection is not recommended in patients with severe kidney disease.
Use of Retefast 18mg Injection is not recommended in patients with severe kidney disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Retefast 18mg Injection
₹33000.0/Injection
Retefuse 18mg Injection
Lupin Ltd
₹32650/injection
1% cheaper
Vascium 18mg Injection
Emcure Pharmaceuticals Ltd
₹28333.32/injection
14% cheaper
Cathlyse 18mg Injection
Biochem Pharmaceutical Industries
₹29750/injection
10% cheaper
Retelex 18mg Injection
Abbott L
₹32700/injection
1% cheaper
Retefast Kit
Cipla Ltd
₹23000/injection
30% cheaper
Quick tips
- It should be given as soon as possible (within 12 hours) after the onset of a heart attack or within 4.5 hours of onset of stroke.
- Let your doctor know immediately if you develop any nosebleeds, gum bleeding, black or tarry stools, or bruising.
- Do not discontinue the medicines started after this injection as it may increase your chances of having another heart attack or stroke.
Fact Box
Chemical Class
Carboxylic Acids Derivatives
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Plasminogen Activators- Thrombolytics
Patient concerns
FAQs
How is Retefast 18mg Injection administered?
Retefast 18mg Injection should be administered under the supervision of a trained healthcare professional or a doctor only and should not be self-administered. The dose will depend on the condition you are being treated for and will be decided by your doctor. Follow your doctor’s instructions carefully to get maximum benefit from Retefast 18mg Injection.
Is Retefast 18mg Injection safe?
Retefast 18mg Injection is safe if used in the dose and duration advised by your doctor. Take it exactly as directed and do not skip any dose. Follow your doctor's instructions carefully and let your doctor know if any of the side effects bother you.
Can the use of Retefast 18mg Injection increase the risk of bleeding?
Yes, Retefast 18mg Injection can increase the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.
What medicines should I avoid while taking Retefast 18mg Injection?
Retefast 18mg Injection can interact with several medicines. If you are already taking Retefast 18mg Injection, do not take any other medicine without talking to your doctor.
When will I feel better after taking Retefast 18mg Injection?
Retefast 18mg Injection reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Retefast 18mg Injection. This does not mean that the medicine is not working, therefore keep taking this medicine as prescribed.
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 384.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1208.
Marketer details
Name: Cipla Ltd
Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹33000
Inclusive of all taxes
10.0 ml in 1 vial
SOLD OUT
Notify me